...
首页> 外文期刊>Frontiers in Cell and Developmental Biology >Role of Cysteine Residues in the Carboxyl-Terminus of the Follicle-Stimulating Hormone Receptor in Intracellular Traffic and Postendocytic Processing
【24h】

Role of Cysteine Residues in the Carboxyl-Terminus of the Follicle-Stimulating Hormone Receptor in Intracellular Traffic and Postendocytic Processing

机译:半胱氨酸残基在卵泡刺激激素受体的羧基末端在细胞内运输和内吞后加工中的作用。

获取原文

摘要

Posttranslational modifications occurring during the biosynthesis of G protein-coupled receptors include glycosylation and palmitoylation at conserved cysteine residues located in the carboxyl-terminus (Ctail) of the receptor. In a number of these receptors, these modifications play an important role in receptor function and particularly, in intracellular trafficking. In the present study, the three cysteine residues present in the carboxyl-terminus of the human FSHR were replaced with glycine by site-directed mutagenesis. Wild-type and mutant (Cys627/629/655Gly) FSHRs were then transiently expressed in HEK-293 cells and analyzed for cell-surface plasma membrane expression, agonist-stimulated signaling and internalization, and postendocytic processing in the abscence and presence of lysosome and/or proteasome inhibitors. Compared with the wild-type FSHR, the triple mutant FSHR exhibited ~70% reduction in plasma membrane expression as well as a profound attenuation in agonist-stimulated cAMP production and ERK1/2 phosphorylation. Incubation of HEK-293 cells expressing the wild-type FSHR with 2-bromopalmitate (palmitoylation inhibitor) for 6 h, decreased plasma membrane expression of the receptor by ~30%. The internalization kinetics and β-arrestin 1 and 2 recruitment were similar between the wild-type and triple mutant FSHR as disclosed by assays performed in non-equilibrium binding conditions and by confocal microscopy. Cells expressing the mutant FSHR recycled the internalized FSHR back to the plasma membrane less efficiently than those expressing the wild-type FSHR, an effect that was counteracted by proteasome but not by lysosome inhibition. These results indicate that replacement of the cysteine residues present in the carboxyl-terminus of the FSHR, impairs receptor trafficking from the endoplasmic reticulum/Golgi apparatus to the plasma membrane and its recycling from endosomes back to the cell surface following agonist-induced internalization. Since in the FSHR these cysteine residues are S-palmitoylated, the data presented emphasize on this posttranslational modification as an important factor for both upward and downward trafficking of this receptor.
机译:在G蛋白偶联受体的生物合成过程中发生的翻译后修饰包括位于受体羧基末端(Ctail)上保守的半胱氨酸残基的糖基化和棕榈酰化。在许多这些受体中,这些修饰在受体功能特别是在细胞内运输中起重要作用。在本研究中,通过定点诱变,将人FSHR羧基末端存在的三个半胱氨酸残基替换为甘氨酸。然后,野生型和突变型(Cys627 / 629 / 655Gly)FSHRs在HEK-293细胞中瞬时表达,并分析了细胞表面质膜的表达,激动剂刺激的信号传导和内在化,以及在缺乏和溶酶体和存在下的内吞后加工过程/或蛋白酶体抑制剂。与野生型FSHR相比,三突变体FSHR的质膜表达降低了约70%,并且在激动剂刺激的cAMP产生和ERK1 / 2磷酸化上有显着衰减。将表达野生型FSHR的HEK-293细胞与2-溴棕榈酸酯(棕榈酸酯化抑制剂)一起孵育6小时,可使受体的质膜表达降低约30%。如在非平衡结合条件下进行的测定和共聚焦显微镜所揭示的,野生型和三突变体FSHR之间的内在动力学以及β-arrestin1和2募集相似。表达突变型FSHR的细胞比表达野生型FSHR的细胞将内化的FSHR再循环回质膜的效率更低,这种作用可被蛋白酶体抵消,但不能被溶酶体抑制。这些结果表明,替换存在于FSHR的羧基末端的半胱氨酸残基,会损害受体从内质网/高尔基体向质膜的转运,并在激动剂诱导的内在化之后将其从内体循环回到细胞表面。由于在FSHR中,这些半胱氨酸残基是S-棕榈糖基化的,因此提供的数据强调了这种翻译后修饰是该受体向上和向下转运的重要因素。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号